Table 2 Characteristics of the study population
Characteristic | N of cases (%), N = 149 |
|---|---|
Gender | |
Male | 82 (55) |
Female | 67 (45) |
Racial or ethnic group | |
Caucasian | 102 (68.5) |
American | 13 (8.7) |
African | 4 (2.7) |
Asian | 4 (2.7) |
Other/non reported | 26 (17.4) |
Underlying chronic diseases | |
Total | 34 (22.8) |
Neurological and metabolic disorders | 8 (5.3) |
Complex genetic syndromes | 5 (3.3) |
Cancers | 5 (3.3) |
Obesity | 5 (3.3) |
Kidney diseases | 2 (1.3) |
Cardiovascular diseases | 2 (1.3) |
Endocrine disorders | 2 (1.3) |
Asthma | 2 (1.3) |
Hematologic diseases | 1 (0.6) |
Rheumatologic diseases | 1 (0.6) |
Immunodeficiency | 1 (0.6) |
Presenting signs/symptoms | |
Fever | 119 (79.9) |
Cough | 34 (22.8) |
Rhinitis | 29 (19.5) |
Dyspnoea | 29 (19.5) |
Diarrhoea | 26 (17.4) |
Vomit | 23 (15.4) |
Pharyngodynia/pharyngitis | 23 (15.4) |
Skin rash | 19 (12.8) |
Abdominal pain | 16 (10.7) |
Conjunctivitis | 13 (8.7) |
Smell and taste alterations | 10 (6.7) |
Seizures | 5 (3.4) |
Chest pain | 5 (3.4) |
Arthralgia | 3 (2) |
Complications | |
Pneumonia | 32 (21.5) |
Severe acute respiratory illness | 13(8.7) |
Acute respiratory distress syndrome | 4 (2.7) |